Adamis Pharmaceuticals Other Liabilities

Adamis Pharmaceuticals (ADMP) currently reports a other liabilities of $0 as of September 2023. That compares with $200K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Adamis Pharmaceuticals's other liabilities history and peer comparisons.

Adamis Pharmaceuticals's other liabilities decreased from $200K to $0 — a 100.0% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Adamis Pharmaceuticals reported $0 in other liabilities as of September 2023. That compares with $200K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Adamis Pharmaceuticals, and consider following ADMP for alerts when major investors trade the stock.

Adamis Pharmaceuticals is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADMP with unrelated industries.